The spatial organization of the tumor immune microenvironment (TIME) is a critical determinant of cancer progression and response to precision therapies. Understanding this complex ecosystem holds ...
Tumor heterogeneity presents a major challenge in effective cancer treatment, particularly in colorectal cancer (CRC), by limiting the efficacy of therapies and driving resistance. Patient-derived ...